Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-16T00:05:48.497Z.
Calculation as of: 2026-09-16T00:05:48.497Z.
Quote observation: 2026-09-15T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 964dea0a62a021cf91ab4a4fff946502237dcf7daab05ef1be43f0b27a35c2c7
PEG RATIO
N/A
Humana Inc.
Market Cap
$47.61B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Humana Inc. (HUM) | $47.61B | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.37B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.71B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $44.39B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $51.23B | N/A |
| Agilent Technologies, Inc. (A)vs › | $42.42B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $54.49B | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.29B | N/A |
| Moderna, Inc. (MRNA)vs › | $57.05B | N/A |
| Centene Corp. (CNC)vs › | $33.41B | N/A |
PEG Ratio
N/A
P/E Ratio
37.5
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
